Robert Comis
Hematology & Oncology · Philadelphia, PANPI 1457414427
Payments from drug & device makers
Across 2 payments — averaging $454,179 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$861K
- Lilly USA, LLC$47K
Across 1 payment — averaging $63,860 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$64K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 1 | $861,181 |
| Lilly USA, LLC | 1 | $47,177 |
How this compares
$908,358 in reported general payments places this provider in the 90th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Philadelphia
- Stephen BagleyPhiladelphia$13.1M
- Stephen SchusterPhiladelphia$9.5M
- Pooja GhataliaPhiladelphia$8.3M
- Corey LangerPhiladelphia$7.7M
- Alfred GarfallPhiladelphia$7.6M
- Charu AggarwalPhiladelphia$7M
- Marcela MausPhiladelphia$4.4M
- Catherine LaiPhiladelphia$3.8M
- James StevensonPhiladelphia$3.4M
- Tara MitchellPhiladelphia$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.